Home › Funds › Stephenson & Company, Inc. › MIST

Stephenson & Company, Inc. position in MIST

MILESTONE PHARMACEUTICALS IN · Health Care

Stephenson & Company, Inc. reported holding 20,000 shares of MIST (MILESTONE PHARMACEUTICALS IN) in its Q2 2026 13F filing — a position valued at US$27K, representing 0.01% of its reported portfolio and ranking #50 among its reported holdings. Stephenson & Company, Inc. has disclosed MIST holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

Latest position (Q2 2026)20.00K sh
Reported value held$26.80K
Portfolio Weight0.01%
First reportedQ3 2025
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Stephenson & Company, Inc.'s MIST position evolved

Stephenson & Company, Inc. first disclosed a stake in MIST in Q3 2025 at 20,000 shares (US$40K). The position peaked in Q4 2025 at 20,000 shares, worth US$40K. Across 4 filings, Stephenson & Company, Inc. held the position steady without any share-count change. The most recent filing (Q2 2026) shows 20,000 shares valued at US$27K.

Quarter by quarter

QuarterSharesValueChange
Q3 2025 20.00K $40.00K New
Q4 2025 20.00K $40.40K Hold
Q1 2026 20.00K $23.80K Hold
Q2 2026 20.00K $26.80K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About MIST and 13F data

MIST (MILESTONE PHARMACEUTICALS IN) is a Health Care company. 31 other funds we track also report a position in MIST — the largest reported positions include Propel Bio Management, LLC (US$10.0M), Pavaki Capital Management LLC (US$8.1M), Simplify Asset Management Inc. (US$4.5M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding MIST

All MIST fund holders →

FAQ

How long has Stephenson & Company, Inc. held MIST?

Stephenson & Company, Inc. has disclosed MIST holdings in 4 of the last 4 reported quarters, going back to Q3 2025.

What is Stephenson & Company, Inc.'s current position in MIST?

As of Q2 2026, Stephenson & Company, Inc. holds 20.00K shares of MIST (MILESTONE PHARMACEUTICALS IN), valued at $26.80K, representing 0.01% of its reported portfolio and ranking #50.

Has Stephenson & Company, Inc. been buying or selling MIST?

In the latest 13F filing (Q2 2026), Stephenson & Company, Inc. held unchanged its position in MIST. The position peaked in Q4 2025 at 20.00K shares.

Which other funds hold MIST?

Other major institutional holders of MIST include Propel Bio Management, LLC, Pavaki Capital Management LLC, Simplify Asset Management Inc., among 31 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.